Horizons North American Infrastructure Devel Index ETF (BLDR) Share Price

CRWD
Crowdstrike price target raised to $372 from $295 at Barclays
Barclays raised the firm's price target on Crowdstrike to $372 from $295 and keeps an Overweight rating on the shares ahead of the Q3 earnings report on November 26. The firm thinks Q3 will represent the trough in ne

LMFAO!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

Someone didn't listen to THE KING:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175401105

Pdufa dates are pdufa dates. For vyvanse it i

TSLA
Tesla price target raised to $270 from $235 at Barclays
Barclays analyst Dan Levy raised the firm's price target on Tesla to $270 from $235 and keeps an Equal Weight rating on the shares. The post-election rally in the shares is largely on a stronger narrative and technical fac

Filing this week? Current by end of month?

You have to realize the IQVIA is actually A LOT higher than this.

Vyvanse is in shortage and TONS of companies don't even have the API to produce it.

The IQVIA is ACTUALLY the original $5.1 billion....................if not even HIGHER.

"IQVIA reported an

Sorry to be blunt with you man, you don’t call losses or having made a gain of $$$ until the stock is sold or at no bid.

Now since your posts show you ragging on RDAR since the “ I got greedy “ Monday after the ATH Friday October 18, you could have sold much higher, and bought Bach a

Elite Pharmaceuticals Receives FDA Approval for Generic Vyvanse
Northvale, New Jersey--(Newsfile Corp. - November 18, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company engaged in the development, manufacture, and distribution of n

IN NASRAT AND KIRKO WE TRUST

$ELTP  "IQVIA reported annual sales for the twelve months ending September 2024 of $4.3 billion for the brand and generic market for this product."

Congrats to Nasrat and team....life changing!

Gonna have to run 3 shifts till January. WOW WOW WOW

Ricco79, No offering required, IPO, Re-IPO, Senior Preferred Offering none required to be released. No Senior conversion to Common required. Not even a buyout of the JPS or Common Shareholders from Treasury. None required to be released. Simply release re-list the companies on the New York Stock Exc

$ELTP Congrats longs!  Generic Vyvanse approved!

Good morning, GV
style="font-size: 1em"I appreciate you very much for adding such value to this community.

style="font-size: 1em"

Wow $300...that would be a home run for so many people.
I was reviewing some of your past posts and that has been a nu

You're the SMARTEST person on the ENTIRE PLANET!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

HOLY SH*T you're PHUCKIN' GOOD!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

Vyvanse could be approved any day this week.

🔴🔴Will AMC OBV go UP-or-DOWN ❌️today❌️?: https://investorshub.advfn.com/uimage/uploads/2023/8/14/plodmAMC_OBV.png
https://investorshub.advfn.com/uimage/uploads/2023/8/3/rgtklAMC_SLF.pnghttps://investorshub.advfn.com/uimage/uploads/2024/8/21/uvuzgAMC

Were golden
https://finance.yahoo.com/news/elite-pharmaceuticals-receives-fda-approval-110000541.html

It’s approved it’s approved, yeah BABY ELTP$$$$$$$$$$$$$$$$$$$$$$$

***** Elite Pharmaceuticals Receives FDA Approval for Generic Vyvanse *****

Northvale, New Jersey--(Newsfile Corp. - November 18, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical

Monday Watchlist: NASDAQ Pre-Market Actives: $APLM $MNDR $TSLL $ELAB $TSLA $NVDA $SMCI

On Watch:
$ILLR News watch early this week
$TSLA On target for $400
$GRLF News today per company.

BEST SELLERS RANK (BSR) IS 693 38 Estimated Sold on Amazon Since OCT 1 - 4TH Quarter 2024
https://investorshub.advfn.com/uimage/uploads/2024/4/24/cnxttVOS_5G_GIF.gif
https://www.amazon.com/Vos-RDGL5GX55-B-01-VOS-5G-Dongle/dp/B0C66KHZLP

NOTE: In theory, when BSR Value Dec

Monday Watchlist: NASDAQ Pre-Market Actives: $APLM $MNDR $TSLL $ELAB $TSLA $NVDA $SMCI

On Watch:
$ILLR News watch early this week
$TSLA On target for $400
$GRLF News today per company.

https://www.electronicspecifier.com/products/cyber-security/navigating-the-surge-of-cyber-threats-in-global-maritime-trade
OK, you know the answer - Wave.

I did get greedy. Bought a total of a little over 13 Million at 25k. It's not a loss of 20k yet, it's a loss of 15k give or take depending on price move, will be 20 k pretty soon. Just wait for this to hit 5s. I have not sold any. Was about to buy crazy thing is that I am half way on recovering my l

PDude, Good to hear from you. I can understand how an argument could be made that this class of drug might provide indirect competition. As investors I don't think we need to be overly concerned.
Sleven,

I don’t think she even does her own charts

But there is some good publicity written 4 star reference’s on Orlando Taddeo’s private owned
Telecom EU company

I have more on the personal side, I’ll keep to myself from first hand, but Orlando checks out legit with